An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

NCT03943147 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient enrollment

Conditions

Lupus Nephritis

Interventions

DRUG: BMS-986165
DRUG: Placebo
DRUG: Mycophenolate Mofetil

Sponsor

Bristol-Myers Squibb